Tci Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tci Co Ltd with three other
companies in this sector in Taiwan:
Tty Biopharm Company Limited
sales of 4.08 billion Taiwanese Dollars [US$139.21 million]
of which 61%
was Anti-Cancer Drug),
Pharmally International Holding Company Ltd
(4.30 billion Taiwanese Dollars [US$146.92 million]
of which 42%
was Glass Bottle), and
Formosa Laboratories, Inc
(2.54 billion Taiwanese Dollars [US$86.67 million]
of which 100%
was Active Pharmaceutical Ingredient).
Tci Co Ltd reported sales of 4.07 billion Taiwanese Dollars (US$138.98 million)
December of 2017.
increase of 31.0%
versus 2016, when the company's sales were 3.11 billion Taiwanese Dollars.
Sales at Tci Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 253%).
Sales of Taiwan saw an increase
32.8% in 2017, from
1.07 billion Taiwanese Dollars to 1.43 billion Taiwanese Dollars.